Maximus Inc (NYSE:MMS), a provider of government services worldwide, has seen its stock price touch a 52-week low, reaching $71.71. This latest price point reflects a significant downturn from the company's performance over the past year, with Maximus Inc experiencing a 1-year change of -15.21%. Despite the decline, InvestingPro data shows the company maintains strong fundamentals with a current ratio of 1.49 and revenue growth of 8.19% over the last twelve months. Investors are closely monitoring the stock as it navigates through the current economic headwinds that have impacted its market valuation. According to InvestingPro analysis, the stock appears undervalued at current levels, with technical indicators suggesting oversold conditions. The company boasts a perfect Piotroski Score of 9, indicating strong financial health, and has maintained dividend payments for 20 consecutive years. For deeper insights, investors can access 8 additional ProTips and comprehensive valuation metrics through InvestingPro's detailed research report.
In other recent news, Maximus Inc., with a strong fiscal year 2024 performance, reported an organic revenue increase of 8.8% and a record adjusted earnings per share (EPS) of $6.11. The company's free cash flow also saw a substantial rise, reaching over $400 million. However, a contract with the U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS) for Contact Center Operations was cancelled. This contract was intended for services that Maximus is currently contracted to provide, with option periods extending up to 2031.
Following a competitive selection process, Maximus's Audit Committee approved the dismissal of Ernst & Young LLP as its independent registered public accounting firm, appointing KPMG LLP to take over auditing responsibilities for the fiscal year ending September 30, 2025. Despite these developments, Maximus is projecting fiscal 2025 revenue to be between $5.275 billion and $5.425 billion, with an adjusted EPS forecasted to be in the range of $5.70 to $6.00 per share. The company continues to maintain strong financial health, as indicated by a perfect Piotroski Score of 9 from InvestingPro's analysis. These are among the recent developments for Maximus Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.